ABCG2 and cancer: Our findings revealed a notable decrease in the intracellular accumulation, efficacy, and cytotoxicity of MTX-211 in cancer cells with a high ABCG2 expression, a phenomenon that could be overcome by suppressing the activity of ABCG2.